Evofem Biosciences, Inc. (EVFM)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.96 Million | -70.41 Million | -146.66 Million | -104.82 Million | -55.09 Million | -56.5 Million |
| Net Income | 52.97 Million | -76.69 Million | -205.19 Million | -142.3 Million | -80.03 Million | -125.71 Million |
| Depreciation & Amortization | 1.78 Million | 1.01 Million | 1.02 Million | 302 Thousand | 263 Thousand | 262 Thousand |
| Deferred income taxes | - | - | 33.95 Million | 36.76 Million | 28.12 Million | - |
| Stock-based compensation | 1.18 Million | 3.31 Million | 8.89 Million | 12.69 Million | 8.57 Million | 17.84 Million |
| Change in working capital | 4.72 Million | 6.01 Million | 10.57 Million | -15.22 Million | -12.67 Million | 3.05 Million |
| Other non-cash items | -66.47 Million | -4.05 Million | 4.06 Million | 2.94 Million | 642 Thousand | 48.05 Million |
| Investing Cash Flow | -4000.00 | -341 Thousand | -2.68 Million | 6.22 Million | -8.11 Million | 2.14 Million |
| Investments in PPE | -4000.00 | -341 Thousand | -2.93 Million | -2.25 Million | -164 Thousand | -7000.00 |
| Acquisitions | - | - | 250 Thousand | 250 Thousand | 250 Thousand | 2.15 Million |
| Investment purchases | - | - | - | -250 Thousand | -8.23 Million | - |
| Sales/Maturities of investments | - | - | - | 8.23 Million | - | - |
| Other Investing Activities | - | - | 250 Thousand | 250 Thousand | 32 Thousand | 250 Thousand |
| Financing Cash Flow | 4.77 Million | 63.14 Million | 90.69 Million | 154.22 Million | 78.07 Million | 54.41 Million |
| Debt repayment | -4.48 Million | -5.6 Million | - | -50 Million | -4.01 Million | - |
| Dividends payments | - | - | - | - | - | -157 Thousand |
| Common Stock Repurchased | - | -18 Thousand | -327 Thousand | -2.86 Million | 75.4 Million | -1.59 Million |
| Common Stock Issuance | 290 Thousand | 57.55 Million | 81.53 Million | 107.96 Million | 78.36 Million | 56.16 Million |
| Other Financing Activities | 290 Thousand | -18 Thousand | 9.48 Million | 157.09 Million | 3.72 Million | 56.16 Million |
| Accounts receivables | -4.61 Million | 5.32 Million | -5.38 Million | -1.06 Million | - | - |
| Accounts payables | 4.09 Million | 4.47 Million | -4000.00 | 4.12 Million | -2.93 Million | 3.79 Million |
| Inventory | 2.1 Million | 1.56 Million | -21 Thousand | -6.01 Million | - | - |
| Other working capital | 3.14 Million | -5.34 Million | 15.98 Million | -12.27 Million | -9.74 Million | -741 Thousand |
| Cash at beginning of period | 3.97 Million | 13.58 Million | 72.25 Million | 16.62 Million | 1.76 Million | 1.7 Million |
| Cash at end of period | 580 Thousand | 4.77 Million | 13.58 Million | 72.25 Million | 16.62 Million | 1.76 Million |
| Capital Expenditure | -4000.00 | -341 Thousand | -2.93 Million | -2.25 Million | -164 Thousand | -7000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.39 Million | -8.81 Million | -58.66 Million | 55.62 Million | 14.86 Million | 60 Thousand |
| Free Cash Flow | -8.97 Million | -70.75 Million | -149.6 Million | -107.08 Million | -55.26 Million | -56.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.35 Million | -4.8 Million | 52.97 Million | -2.11 Million | 66 Million | -8.55 Million |
| Depreciation & Amortization | 42 Thousand | 59 Thousand | 1.78 Million | 67 Thousand | 37 Thousand | 173 Thousand |
| Deferred income taxes | - | - | - | - | -68.65 Million | 1.95 Million |
| Stock-based compensation | 219 Thousand | 237 Thousand | 1.18 Million | 246 Thousand | 258 Thousand | 268 Thousand |
| Change in working capital | -4000.00 | 2.71 Million | 4.72 Million | 4.28 Million | -619 Thousand | 3.85 Million |
| Other non-cash items | -2.12 Million | 1.18 Million | -66.47 Million | -6.49 Million | 612 Thousand | 814 Thousand |
| Investing Cash Flow | - | -14 Thousand | -4000.00 | - | - | -1000.00 |
| Investments in PPE | - | -14 Thousand | -4000.00 | - | - | -1000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.14 Million | - | 4.77 Million | 340 Thousand | 2.13 Million | 597 Thousand |
| Debt repayment | -1.39 Million | - | -4.48 Million | -224 Thousand | -1 Million | -498 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 290 Thousand | 116 Thousand | 14 Thousand | 99 Thousand |
| Other Financing Activities | -253 Thousand | - | 290 Thousand | 116 Thousand | 3.12 Million | 996 Thousand |
| Accounts receivables | -311 Thousand | 1.43 Million | -4.61 Million | 584 Thousand | -1.12 Million | 2.2 Million |
| Accounts payables | -261 Thousand | -726 Thousand | 4.09 Million | 2.87 Million | -952 Thousand | -1.64 Million |
| Inventory | 246 Thousand | 391 Thousand | 2.1 Million | 758 Thousand | -357 Thousand | 1.8 Million |
| Other working capital | 322 Thousand | 1.61 Million | 3.14 Million | 68 Thousand | 1.81 Million | 1.48 Million |
| Cash at beginning of period | 689 Thousand | 580 Thousand | 3.97 Million | 410 Thousand | 636 Thousand | 1.53 Million |
| Cash at end of period | 692 Thousand | 689 Thousand | 580 Thousand | 580 Thousand | 410 Thousand | 636 Thousand |
| Capital Expenditure | - | -14 Thousand | -4000.00 | - | - | -1000.00 |
| Effect of forex changes on cash | - | - | - | - | - | 958 Thousand |
| Net cash flow / Change in cash | 3000.00 | 109 Thousand | -3.39 Million | 170 Thousand | -226 Thousand | -898 Thousand |
| Free Cash Flow | -1.14 Million | 109 Thousand | -8.97 Million | -170 Thousand | -2.36 Million | -1.49 Million |
AAVC
FBPI
0691
OXM
BTDPF
5287